1/3 Moderna, a leading pharmaceutical company, has submitted an updated application for its COVID-19 vaccine to the prestigious U.S. Food and Drug Administration (FDA). This application is specifically for Moderna’s messenger RNA vaccine, which has shown promising results in combating the virus. The latest version of the vaccine is designed to address the XBB.1.5 subvariant …
The Centers for Disease Control and Prevention (CDC) announced on Thursday that sales of e-cigarettes have seen a significant rise of nearly 50% between 2020 and 2022[i]. This data, based on a study conducted by the CDC, reveals an upward trend in e-cigarette sales despite increasing regulations on marketing and growing concerns around the health …
A federal appeals court has made a significant ruling regarding the availability of abortion pills in the United States. The court’s decision, which came late Wednesday, preserved access to the abortion pill while imposing some restrictions. This ruling adds to the ongoing debate and uncertainty surrounding abortion rights in the country. The majority of abortions …
May 12 (UPI) — The Food and Drug Administration has granted approval for a novel medication to address the symptoms of menopause, specifically moderate to severe vasomotor symptoms, commonly referred to as “hot flashes.” Introducing Veozah, an innovative non-hormonal treatment also known as fezolinetant. This groundbreaking medication revolves around the blocking of the neurokinin 3 …
Neuralink, a neurotechnology company owned by Elon Musk, announced on Friday that it has received approval from the U.S. Food and Drug Administration (FDA) for a human clinical trial of its brain implant. The company has been working since 2017 to implant electrodes into human brains in order to enhance their computer interface. While the …
May 30 (UPI) — The Food and Drug Administration (FDA) has put forward a revolutionary proposal for a new medication guide that aims to enhance patient understanding and safety while potentially reducing hospitalizations and saving lives. Termed as “Patient Medication Information,” this innovative guide is designed to deliver clear and concise information about prescription drugs …
Pfizer’s respiratory syncytial virus vaccine, called ABRYSVO, was approved by the US Food and Drug Administration on Wednesday. This is the second RSV vaccine that has been approved by the FDA for individuals above 60 years of age, the first being Arexvy, by GSK. The clinical trial of ABRYSVO involved roughly 37,000 participants and, according …
On Thursday, the U.S. Food and Drug Administration’s Antimicrobial Drugs Advisory Committee unanimously voted in favor of approving a new respiratory syncytial virus (RSV) treatment for infants. The committee voted 21 to 0 in favor of the recommendation. RSV, also known as human respiratory syncytial virus, is a common and contagious virus that affects the …